Thu-12-04-2018, 13:11 PM
(Thu-12-04-2018, 12:42 PM)MrGnomusy Wrote: It feels as though Skilarence was concocted haphazardly without doing proper research as to what makes it work optimally. All to make a small buck in an untapped market...
That is not completely the case I think. They have seen the necessity to have an extra registered DMF product available wide in the European market, as DMF is quite an interesting product, because it influences the immune system in a very positive way with those people who suffer from at disturbance in that. It works for Psoriasis, Psoriatic Arthritis, Multiple Sclerosis, Crohn's, Lichen Sclerosis even for bed sores and more. A leading dermatologist in the Netherlands, dr. Bing Thio, once said: DMF is the aspirin of the future for a certain type of disease.
Almiral is a small spanish pharmacist. They somehow see the importance of DMF for the population and have thought to contribute on that. In that sense I believe them.
The only thing is: They did not do their homework.
Already for many, many years we know that a slow release version is easier to digest. Why didn't they make that? They appear not to have an explanation for that.